Skip to main content

AI

By Dave Muoio | 01:28 pm | October 21, 2020
Quantib and Ezra's automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc's algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries.
By Dr. Liz Kwo | 01:00 pm | September 11, 2020
Dr. Liz Kwo breaks down the data and technology-enabled healthcare tools being adopted by next-generation payers and providers.
By Dave Muoio | 05:15 pm | August 12, 2020
A recent review of Medicare claims suggests a machine learning algorithm could flag individuals at higher risk of infection or help prevent outbreaks within skilled nursing facilities.
By Dave Muoio | 12:12 pm | August 05, 2020
The company's complete blood count analyzer uses artificial intelligence to quickly measure biomarkers from a fingerstick or venous sample.
By Rachel McArthur | 09:28 am | July 20, 2020
The AI medical software solution reportedly identifies abnormalities in body fluids and tissues, and is currently able to diagnose eight diseases, including rare genetic disorders.
By Laura Lovett | 03:59 pm | May 28, 2020
Dr. Ran Balicer, chief innovation officer of Israel’s Clalit Research Institute, talks using tech to catch health issues before they become serious at HIMSS20 Digital. 
By Dave Muoio | 01:21 pm | May 26, 2020
insitro unveiled a $143 million Series B round on the same day that fellow machine learning company Exscientia highlighted its own $60 million Series C raise.
By Dave Muoio | 03:56 pm | May 14, 2020
AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.
By Dave Muoio | 03:55 pm | April 27, 2020
A new study suggests that a deep learning system would save on the roughly two minutes of human labor required to grade each case, although a semi-automated approach was found to drive the greatest savings for large programs.
By Bradley Merrill Thompson | 04:46 pm | April 24, 2020
Epstein Becker & Green's Bradley Merrill Thompson describes the agency's current trajectory for regulation of patient-facing and provider-facing telehealth products that incorporate AI.